Geron Corporation

Geron Corporation is the first biopharmaceutical company to focus exclusively on the development of therapeutic products for diseases of aging, including cancer. Geron's ability to address a diversity of age-related disease states is based on insights into the fundamental biological mechanisms of cellular aging - and conversely, into the process by which cancer cells escape aging by becoming immortal. Geron is a biopharmaceutical company focused on discovering, developing and commercializing therapeutic and diagnostic products for applications in oncology, drug discovery and regenerative medicine. Geron's product development programs are based upon three patented core technologies: telomerase (immmortality cells), human pluripotent stem cells (cell production) and nuclear transfer (for cloning).

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Diagnostics

Therapeutic targets:

- Genetics

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: